NYLI Candriam U.S. Mid Cap Equity ETF (IQSM)

Assets	$212.15M
Expense Ratio	0.15%
PE Ratio	21.26
Shares Out	6.23M
Dividend (ttm)	$0.41
Dividend Yield	1.23%
Ex-Dividend Date	Sep 19, 2025
Payout Frequency	Quarterly
Payout Ratio	26.20%

Volume	3,621
Open	33.66
Previous Close	33.63
Day's Range	33.66 - 34.11
52-Week Low	26.78
52-Week High	35.44
Beta	1.22
Holdings	228
Inception Date	Oct 25, 2022

About IQSM

Fund Home Page

The NYLI Candriam U.S. Mid Cap Equity ETF (IQSM) is an exchange-traded fund that is based on the NYLI Candriam U.S. Mid Cap Equity index. The fund tracks a market cap-weighted index that provides exposure to US mid-cap stocks that meet environmental, social, and corporate governance criteria. IQSM was launched on Oct 25, 2022 and is issued by New York Life Investments.

• Asset Class: Equity
• Category: Mid-Cap Blend
• Region: North America
• Stock Exchange: NYSEARCA
• Ticker Symbol: IQSM
• ETF Provider: New York Life Investments
• Index Tracked: NYLI Candriam U.S. Mid Cap Equity Index

Top 10 Holdings

11.16% of assets

Name	Symbol	Weight
Insmed Incorporated	INSM	1.66%
Comfort Systems USA, Inc.	FIX	1.57%
Credo Technology Group Holding Ltd	CRDO	1.27%
Ciena Corporation	CIEN	1.24%
Tapestry, Inc.	TPR	1.07%
Twilio Inc.	TWLO	0.91%
nVent Electric plc	NVT	0.87%
Guidewire Software, Inc.	GWRE	0.86%
United Therapeutics Corporation	UTHR	0.86%
C.H. Robinson Worldwide, Inc.	CHRW	0.85%

Dividends

Ex-Dividend	Amount	Pay Date
Sep 19, 2025	$0.10566	Sep 25, 2025
Jun 20, 2025	$0.09509	Jun 26, 2025
Mar 21, 2025	$0.08091	Mar 27, 2025
Dec 20, 2024	$0.13287	Dec 26, 2024
Sep 20, 2024	$0.10168	Sep 25, 2024
Jun 21, 2024	$0.06704	Jun 26, 2024

Performance

IQSM had a total return of 4.21% in the past year, including dividends. Since the fund's inception, the average annual return has been 10.46%.